Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity
The work described in this study aimed to express CYP2C8 wild-type and mutant proteins in bacterial expression system and to use the expressed proteins to investigate the structural and functional consequences of a reported allele CYP2C8*4 (carrying Ile264Met substitution) on protein activity. Ile26...
Gespeichert in:
Veröffentlicht in: | DRUG METABOLISM AND PHARMACOKINETICS 2008-01, Vol.23 (3), p.165-174 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 174 |
---|---|
container_issue | 3 |
container_start_page | 165 |
container_title | DRUG METABOLISM AND PHARMACOKINETICS |
container_volume | 23 |
creator | Singh, Rajinder Ting, Jonathan G. Pan, Yan Teh, Lay Kek Ismail, Rusli Ong, Chin Eng |
description | The work described in this study aimed to express CYP2C8 wild-type and mutant proteins in bacterial expression system and to use the expressed proteins to investigate the structural and functional consequences of a reported allele CYP2C8*4 (carrying Ile264Met substitution) on protein activity. Ile264 was replaced by three different amino acids resulting in three mutant constructs, 2C8I264M, 2C8I264R and 2C8I264D. The presence of isoleucine at position 264 in CYP2C8 was found to be important for proper haem insertion and protein folding; whereas bulkier or charged residues were highly disruptive resulting in inactive proteins with minimum spectral and catalytic activities. This was evidenced from the low levels of Soret peak at 450 nm and negligible levels of tolbutamide methylhydroxylase activity. Kinetic study using paclitaxel indicated that all three mutants exhibited only 9.7 to 35.4% of the activity level observed in the wild-type. In addition, the mutants were more sensitive to proteinase K digestion, indicating a possible alteration of conformation. The combined effects of protein instability and compromised catalytic activity resulted in defective CYP2C8 protein which may have clinical implications in carriers of CYP2C8*4, particularly in terms of their capacity to clear potent drugs and their susceptibility to adverse drug reactions. |
doi_str_mv | 10.2133/dmpk.23.165 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2133_dmpk_23_165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347436715301786</els_id><sourcerecordid>S1347436715301786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c587t-e05122355999f67332dc9e4ed2aa6907daf94441acaba61aa6908204be9c514f3</originalsourceid><addsrcrecordid>eNptkE1LwzAYgIMofkxP3iV36XzzJumHt1GcG0wU0YOnkKUpZLbNSLvB_r3ZJnjxkjckDw_JQ8gtgzEyzh-qdv09Rj5mqTwhlyzPIYEC4TTuucgSwdPsglz1_QqAcynwnFywXGaCI1wSNd10ZnC-0w19942lvqbzxmIqqOto-fWGZf5IXzaD3kM9ndS1NQOdadvSeWd8WPtwuKK6q2ipB93sBmfoJEq3bthdk7NaN729-Z0j8jl9-ihnyeL1eV5OFomReTYkFiRD5FIWRVGnGedYmcIKW6HWaQFZpetCCMG00UudssNhjiCWtjCSiZqPyP3Ra4Lv-2BrtQ6u1WGnGKh9JrXPpJCrmCnSd0d6vVm2tvpjf7tEYHoE4q0zuvFd4zqrVn4TYqleGc9aO-ilQoBcASAHHodQEPVxyYRAjlkaRfIosvHzW2eD6o2znYnaEEOqyrt_X_gD4vOKpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Singh, Rajinder ; Ting, Jonathan G. ; Pan, Yan ; Teh, Lay Kek ; Ismail, Rusli ; Ong, Chin Eng</creator><creatorcontrib>Singh, Rajinder ; Ting, Jonathan G. ; Pan, Yan ; Teh, Lay Kek ; Ismail, Rusli ; Ong, Chin Eng ; International Medical University ; Universiti Sains Malaysia ; Pharmacogenetics Research Group ; School of Pharmacy and Health Sciences ; Faculty of Pharmacy ; Institute for Research in Molecular Medicine ; Universiti Teknologi MARA</creatorcontrib><description>The work described in this study aimed to express CYP2C8 wild-type and mutant proteins in bacterial expression system and to use the expressed proteins to investigate the structural and functional consequences of a reported allele CYP2C8*4 (carrying Ile264Met substitution) on protein activity. Ile264 was replaced by three different amino acids resulting in three mutant constructs, 2C8I264M, 2C8I264R and 2C8I264D. The presence of isoleucine at position 264 in CYP2C8 was found to be important for proper haem insertion and protein folding; whereas bulkier or charged residues were highly disruptive resulting in inactive proteins with minimum spectral and catalytic activities. This was evidenced from the low levels of Soret peak at 450 nm and negligible levels of tolbutamide methylhydroxylase activity. Kinetic study using paclitaxel indicated that all three mutants exhibited only 9.7 to 35.4% of the activity level observed in the wild-type. In addition, the mutants were more sensitive to proteinase K digestion, indicating a possible alteration of conformation. The combined effects of protein instability and compromised catalytic activity resulted in defective CYP2C8 protein which may have clinical implications in carriers of CYP2C8*4, particularly in terms of their capacity to clear potent drugs and their susceptibility to adverse drug reactions.</description><identifier>ISSN: 1347-4367</identifier><identifier>EISSN: 1880-0920</identifier><identifier>DOI: 10.2133/dmpk.23.165</identifier><identifier>PMID: 18574320</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amino Acid Substitution ; Animals ; Aryl Hydrocarbon Hydroxylases - genetics ; Aryl Hydrocarbon Hydroxylases - metabolism ; Catalysis ; Catalytic Domain ; Cloning, Molecular ; CYP2C84 ; Cytochrome P-450 CYP2C8 ; DNA Primers ; Endopeptidase K - metabolism ; Enzyme Stability ; Escherichia coli - genetics ; genetic polymorphism ; Heme - metabolism ; Humans ; Isoleucine - genetics ; Isoleucine - physiology ; Mutagenesis, Site-Directed ; NADPH-Ferrihemoprotein Reductase - genetics ; paclitaxel ; Paclitaxel - metabolism ; Paclitaxel - pharmacology ; pharmacogenomics ; Polymorphism, Genetic ; Protein Folding ; Rats ; site-directed mutagenesis ; Substrate Specificity ; Tolbutamide - metabolism ; Tolbutamide - pharmacology</subject><ispartof>DRUG METABOLISM AND PHARMACOKINETICS, 2008-01, Vol.23 (3), p.165-174</ispartof><rights>2008 The Japanese Society for the Study of Xenobiotics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c587t-e05122355999f67332dc9e4ed2aa6907daf94441acaba61aa6908204be9c514f3</citedby><cites>FETCH-LOGICAL-c587t-e05122355999f67332dc9e4ed2aa6907daf94441acaba61aa6908204be9c514f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18574320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Rajinder</creatorcontrib><creatorcontrib>Ting, Jonathan G.</creatorcontrib><creatorcontrib>Pan, Yan</creatorcontrib><creatorcontrib>Teh, Lay Kek</creatorcontrib><creatorcontrib>Ismail, Rusli</creatorcontrib><creatorcontrib>Ong, Chin Eng</creatorcontrib><creatorcontrib>International Medical University</creatorcontrib><creatorcontrib>Universiti Sains Malaysia</creatorcontrib><creatorcontrib>Pharmacogenetics Research Group</creatorcontrib><creatorcontrib>School of Pharmacy and Health Sciences</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Institute for Research in Molecular Medicine</creatorcontrib><creatorcontrib>Universiti Teknologi MARA</creatorcontrib><title>Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity</title><title>DRUG METABOLISM AND PHARMACOKINETICS</title><addtitle>Drug Metab Pharmacokinet</addtitle><description>The work described in this study aimed to express CYP2C8 wild-type and mutant proteins in bacterial expression system and to use the expressed proteins to investigate the structural and functional consequences of a reported allele CYP2C8*4 (carrying Ile264Met substitution) on protein activity. Ile264 was replaced by three different amino acids resulting in three mutant constructs, 2C8I264M, 2C8I264R and 2C8I264D. The presence of isoleucine at position 264 in CYP2C8 was found to be important for proper haem insertion and protein folding; whereas bulkier or charged residues were highly disruptive resulting in inactive proteins with minimum spectral and catalytic activities. This was evidenced from the low levels of Soret peak at 450 nm and negligible levels of tolbutamide methylhydroxylase activity. Kinetic study using paclitaxel indicated that all three mutants exhibited only 9.7 to 35.4% of the activity level observed in the wild-type. In addition, the mutants were more sensitive to proteinase K digestion, indicating a possible alteration of conformation. The combined effects of protein instability and compromised catalytic activity resulted in defective CYP2C8 protein which may have clinical implications in carriers of CYP2C8*4, particularly in terms of their capacity to clear potent drugs and their susceptibility to adverse drug reactions.</description><subject>Amino Acid Substitution</subject><subject>Animals</subject><subject>Aryl Hydrocarbon Hydroxylases - genetics</subject><subject>Aryl Hydrocarbon Hydroxylases - metabolism</subject><subject>Catalysis</subject><subject>Catalytic Domain</subject><subject>Cloning, Molecular</subject><subject>CYP2C84</subject><subject>Cytochrome P-450 CYP2C8</subject><subject>DNA Primers</subject><subject>Endopeptidase K - metabolism</subject><subject>Enzyme Stability</subject><subject>Escherichia coli - genetics</subject><subject>genetic polymorphism</subject><subject>Heme - metabolism</subject><subject>Humans</subject><subject>Isoleucine - genetics</subject><subject>Isoleucine - physiology</subject><subject>Mutagenesis, Site-Directed</subject><subject>NADPH-Ferrihemoprotein Reductase - genetics</subject><subject>paclitaxel</subject><subject>Paclitaxel - metabolism</subject><subject>Paclitaxel - pharmacology</subject><subject>pharmacogenomics</subject><subject>Polymorphism, Genetic</subject><subject>Protein Folding</subject><subject>Rats</subject><subject>site-directed mutagenesis</subject><subject>Substrate Specificity</subject><subject>Tolbutamide - metabolism</subject><subject>Tolbutamide - pharmacology</subject><issn>1347-4367</issn><issn>1880-0920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1LwzAYgIMofkxP3iV36XzzJumHt1GcG0wU0YOnkKUpZLbNSLvB_r3ZJnjxkjckDw_JQ8gtgzEyzh-qdv09Rj5mqTwhlyzPIYEC4TTuucgSwdPsglz1_QqAcynwnFywXGaCI1wSNd10ZnC-0w19942lvqbzxmIqqOto-fWGZf5IXzaD3kM9ndS1NQOdadvSeWd8WPtwuKK6q2ipB93sBmfoJEq3bthdk7NaN729-Z0j8jl9-ihnyeL1eV5OFomReTYkFiRD5FIWRVGnGedYmcIKW6HWaQFZpetCCMG00UudssNhjiCWtjCSiZqPyP3Ra4Lv-2BrtQ6u1WGnGKh9JrXPpJCrmCnSd0d6vVm2tvpjf7tEYHoE4q0zuvFd4zqrVn4TYqleGc9aO-ilQoBcASAHHodQEPVxyYRAjlkaRfIosvHzW2eD6o2znYnaEEOqyrt_X_gD4vOKpQ</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Singh, Rajinder</creator><creator>Ting, Jonathan G.</creator><creator>Pan, Yan</creator><creator>Teh, Lay Kek</creator><creator>Ismail, Rusli</creator><creator>Ong, Chin Eng</creator><general>Elsevier Ltd</general><general>Japanese Society for the Study of Xenobiotics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080101</creationdate><title>Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity</title><author>Singh, Rajinder ; Ting, Jonathan G. ; Pan, Yan ; Teh, Lay Kek ; Ismail, Rusli ; Ong, Chin Eng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c587t-e05122355999f67332dc9e4ed2aa6907daf94441acaba61aa6908204be9c514f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Amino Acid Substitution</topic><topic>Animals</topic><topic>Aryl Hydrocarbon Hydroxylases - genetics</topic><topic>Aryl Hydrocarbon Hydroxylases - metabolism</topic><topic>Catalysis</topic><topic>Catalytic Domain</topic><topic>Cloning, Molecular</topic><topic>CYP2C84</topic><topic>Cytochrome P-450 CYP2C8</topic><topic>DNA Primers</topic><topic>Endopeptidase K - metabolism</topic><topic>Enzyme Stability</topic><topic>Escherichia coli - genetics</topic><topic>genetic polymorphism</topic><topic>Heme - metabolism</topic><topic>Humans</topic><topic>Isoleucine - genetics</topic><topic>Isoleucine - physiology</topic><topic>Mutagenesis, Site-Directed</topic><topic>NADPH-Ferrihemoprotein Reductase - genetics</topic><topic>paclitaxel</topic><topic>Paclitaxel - metabolism</topic><topic>Paclitaxel - pharmacology</topic><topic>pharmacogenomics</topic><topic>Polymorphism, Genetic</topic><topic>Protein Folding</topic><topic>Rats</topic><topic>site-directed mutagenesis</topic><topic>Substrate Specificity</topic><topic>Tolbutamide - metabolism</topic><topic>Tolbutamide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Rajinder</creatorcontrib><creatorcontrib>Ting, Jonathan G.</creatorcontrib><creatorcontrib>Pan, Yan</creatorcontrib><creatorcontrib>Teh, Lay Kek</creatorcontrib><creatorcontrib>Ismail, Rusli</creatorcontrib><creatorcontrib>Ong, Chin Eng</creatorcontrib><creatorcontrib>International Medical University</creatorcontrib><creatorcontrib>Universiti Sains Malaysia</creatorcontrib><creatorcontrib>Pharmacogenetics Research Group</creatorcontrib><creatorcontrib>School of Pharmacy and Health Sciences</creatorcontrib><creatorcontrib>Faculty of Pharmacy</creatorcontrib><creatorcontrib>Institute for Research in Molecular Medicine</creatorcontrib><creatorcontrib>Universiti Teknologi MARA</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>DRUG METABOLISM AND PHARMACOKINETICS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Rajinder</au><au>Ting, Jonathan G.</au><au>Pan, Yan</au><au>Teh, Lay Kek</au><au>Ismail, Rusli</au><au>Ong, Chin Eng</au><aucorp>International Medical University</aucorp><aucorp>Universiti Sains Malaysia</aucorp><aucorp>Pharmacogenetics Research Group</aucorp><aucorp>School of Pharmacy and Health Sciences</aucorp><aucorp>Faculty of Pharmacy</aucorp><aucorp>Institute for Research in Molecular Medicine</aucorp><aucorp>Universiti Teknologi MARA</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity</atitle><jtitle>DRUG METABOLISM AND PHARMACOKINETICS</jtitle><addtitle>Drug Metab Pharmacokinet</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>23</volume><issue>3</issue><spage>165</spage><epage>174</epage><pages>165-174</pages><issn>1347-4367</issn><eissn>1880-0920</eissn><abstract>The work described in this study aimed to express CYP2C8 wild-type and mutant proteins in bacterial expression system and to use the expressed proteins to investigate the structural and functional consequences of a reported allele CYP2C8*4 (carrying Ile264Met substitution) on protein activity. Ile264 was replaced by three different amino acids resulting in three mutant constructs, 2C8I264M, 2C8I264R and 2C8I264D. The presence of isoleucine at position 264 in CYP2C8 was found to be important for proper haem insertion and protein folding; whereas bulkier or charged residues were highly disruptive resulting in inactive proteins with minimum spectral and catalytic activities. This was evidenced from the low levels of Soret peak at 450 nm and negligible levels of tolbutamide methylhydroxylase activity. Kinetic study using paclitaxel indicated that all three mutants exhibited only 9.7 to 35.4% of the activity level observed in the wild-type. In addition, the mutants were more sensitive to proteinase K digestion, indicating a possible alteration of conformation. The combined effects of protein instability and compromised catalytic activity resulted in defective CYP2C8 protein which may have clinical implications in carriers of CYP2C8*4, particularly in terms of their capacity to clear potent drugs and their susceptibility to adverse drug reactions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>18574320</pmid><doi>10.2133/dmpk.23.165</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-4367 |
ispartof | DRUG METABOLISM AND PHARMACOKINETICS, 2008-01, Vol.23 (3), p.165-174 |
issn | 1347-4367 1880-0920 |
language | eng |
recordid | cdi_crossref_primary_10_2133_dmpk_23_165 |
source | J-STAGE Free; MEDLINE; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Amino Acid Substitution Animals Aryl Hydrocarbon Hydroxylases - genetics Aryl Hydrocarbon Hydroxylases - metabolism Catalysis Catalytic Domain Cloning, Molecular CYP2C84 Cytochrome P-450 CYP2C8 DNA Primers Endopeptidase K - metabolism Enzyme Stability Escherichia coli - genetics genetic polymorphism Heme - metabolism Humans Isoleucine - genetics Isoleucine - physiology Mutagenesis, Site-Directed NADPH-Ferrihemoprotein Reductase - genetics paclitaxel Paclitaxel - metabolism Paclitaxel - pharmacology pharmacogenomics Polymorphism, Genetic Protein Folding Rats site-directed mutagenesis Substrate Specificity Tolbutamide - metabolism Tolbutamide - pharmacology |
title | Functional Role of Ile264 in CYP2C8: Mutations Affect Haem Incorporation and Catalytic Activity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T06%3A04%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20Role%20of%20Ile264%20in%20CYP2C8:%20Mutations%20Affect%20Haem%20Incorporation%20and%20Catalytic%20Activity&rft.jtitle=DRUG%20METABOLISM%20AND%20PHARMACOKINETICS&rft.au=Singh,%20Rajinder&rft.aucorp=International%20Medical%20University&rft.date=2008-01-01&rft.volume=23&rft.issue=3&rft.spage=165&rft.epage=174&rft.pages=165-174&rft.issn=1347-4367&rft.eissn=1880-0920&rft_id=info:doi/10.2133/dmpk.23.165&rft_dat=%3Celsevier_cross%3ES1347436715301786%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18574320&rft_els_id=S1347436715301786&rfr_iscdi=true |